|
|
|
HIV-1 tropism |
| Aikichi Iwamoto1,Noriaki Hosoya2,Ai Kawana-Tachikawa3, |
| 1.Division of Infectious
Diseases, Advanced Clinical Research Center, Institute of Medical
Science, The University of Tokyo, Tokyo 108-8639, Japan；€International Research
Center for Infectious Diseases, Institute of Medical Science, The
University of Tokyo, Tokyo 108-8639, Japan；€Research Center for
Asian Infectious Diseases, Institute of Medical Science, The University
of Tokyo, Tokyo 108-8639, Japan; 2.€International Research
Center for Infectious Diseases, Institute of Medical Science, The
University of Tokyo, Tokyo 108-8639, Japan; 3.Division of Infectious
Diseases, Advanced Clinical Research Center, Institute of Medical
Science, The University of Tokyo, Tokyo 108-8639, Japan; |
|
|
Asj?, B., Morfeldt-M?nson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., and Feny?, E.M.(1986). Replicative capacity of human immunodeficiency virusfrom patients with varying severity of HIV infection. Lancet2, 660―662.
|
|
Barr?-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983). Isolation of a T-lymphotropicretrovirus from a patient at risk for acquired immune deficiency syndrome(AIDS). Science220, 868―871.
|
|
Berger, E.A., Doms, R.W., Feny?, E.M., Korber, B.T., Littman, D.R., Moore, J.P., Sattentau, Q.J., Schuitemaker, H., Sodroski, J., and Weiss, R.A.(1998). A new classification for HIV-1. Nature391, 240.
doi: 10.1038/34571
|
|
Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A., and Mackay, C.R.(1997). The HIVcoreceptors CXCR4 and CCR5 are differentially expressed and regulatedon human T lymphocytes. Proc Natl AcadSci U S A94, 1925―1930.
doi: 10.1073/pnas.94.5.1925
|
|
Braun, P., and Wiesmann, F.(2007). Phenotypicassays for the determination of coreceptor tropism in HIV-1 infectedindividuals. Eur J Med Res12, 463―472.
|
|
Centers for Disease Control (CDC), C.f.D.C. (1981). Pneumocystis pneumonia–LosAngeles. MMWR Morb Mortal Wkly Rep 30, 250―252.
|
|
Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C., and Lusso, P.(1995). Identification ofRANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factorsproduced by CD8+ T cells. Science270, 1811―1815.
doi: 10.1126/science.270.5243.1811
|
|
Collman, R., Hassan, N.F., Walker, R., Godfrey, B., Cutilli, J., Hastings, J.C., Friedman, H., Douglas, S.D., and Nathanson, N.(1989). Infectionof monocyte-derived macrophages with human immunodeficiency virustype 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1show distinctive patterns of replication in a panel of cell types. J Exp Med170, 1149―1163.
doi: 10.1084/jem.170.4.1149
|
|
de Roda Husman, A.M., Koot, M., Cornelissen, M., Keet, I.P., Brouwer, M., Broersen, S.M., Bakker, M., Roos, M.T., Prins, M., de Wolf, F., et al. (1997). Association between CCR5 genotype and the clinical course of HIV-1infection. Ann Intern Med127, 882―890.
|
|
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R.E., Hill, C.M., et al. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature381, 661―666.
doi: 10.1038/381661a0
|
|
Feng, Y., Broder, C.C., Kennedy, P.E., and Berger, E.A.(1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane,G protein-coupled receptor. Science272, 872―877.
doi: 10.1126/science.272.5263.872
|
|
Fouchier, R.A., Groenink, M., Kootstra, N.A., Tersmette, M., Huisman, H.G., Miedema, F., and Schuitemaker, H.(1992). Phenotype-associated sequence variation in the thirdvariable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol66, 3183―3187.
|
|
Gottlieb, M.S., Schroff, R., Schanker, H.M., Weisman, J.D., Fan, P.T., Wolf, R.A., and Saxon, A.(1981). Pneumocystis carinii pneumonia and mucosal candidiasisin previously healthy homosexual men: evidence of a new acquired cellularimmunodeficiency. N Engl J Med305, 1425―1431.
|
|
Huang, C.C., Tang, M., Zhang, M.Y., Majeed, S., Montabana, E., Stanfield, R.L., Dimitrov, D.S., Korber, B., Sodroski, J., Wilson, I.A., et al.(2005). Structure of a V3-containing HIV-1gp120 core. Science310, 1025―1028.
doi: 10.1126/science.1118398
|
|
Huang, W., Eshleman, S.H., Toma, J., Fransen, S., Stawiski, E., Paxinos, E.E., Whitcomb, J.M., Young, A.M., Donnell, D., Mmiro, F., et al. (2007). Coreceptor tropism in human immunodeficiencyvirus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneouscomposition of viral populations. J Virol81, 7885―7893.
doi: 10.1128/JVI.00218-07
|
|
Huang, W., Toma, J., Fransen, S., Stawiski, E., Reeves, J.D., Whitcomb, J.M., Parkin, N., and Petropoulos, C.J.(2008). Coreceptortropism can be influenced by amino acid substitutions in the gp41transmembrane subunit of human immunodeficiency virus type 1 envelopeprotein. J Virol82, 5584―5593.
doi: 10.1128/JVI.02676-07
|
|
Hwang, S.S., Boyle, T.J., Lyerly, H.K., and Cullen, B.R.(1991). Identification of the envelope V3 loop as the primarydeterminant of cell tropism in HIV-1. Science253, 71―74.
doi: 10.1126/science.1905842
|
|
Japour, A.J., Welles, S., D'Aquila, R.T., Johnson, V.A., Richman, D.D., Coombs, R.W., Reichelderfer, P.S., Kahn, J.O., Crumpacker, C.S., and Kuritzkes, D.R.(1995). Prevalence and clinical significance of zidovudine resistancemutations in human immunodeficiency virus isolated from patients afterlong-term zidovudine treatment. AIDS Clinical Trials Group 116B/117Study Team and the Virology Committee Resistance Working Group. J Infect Dis171, 1172―1179.
|
|
Jensen, M.A., Coetzer, M., van 't Wout, A.B., Morris, L., and Mullins, J.I.(2006). A reliable phenotype predictor for human immunodeficiencyvirus type 1 subtype C based on envelope V3 sequences. J Virol80, 4698―4704.
|
|
Koot, M., Vos, A.H., Keet, R.P., de Goede, R.E., Dercksen, M.W., Terpstra, F.G., Coutinho, R.A., Miedema, F., and Tersmette, M.(1992). HIV-1biological phenotype in long-term infected individuals evaluated withan MT-2 cocultivation assay. AIDS6, 49―54.
|
|
Kuritzkes, D.R.(2009). HIV-1 entry inhibitors: an overview. Curr Opin HIV AIDS4, 82―87.
doi: 10.1097/COH.0b013e328322402e
|
|
Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A., and Axel, R. (1986). The T4 gene encodesthe AIDS virus receptor and is expressed in the immune system andthe brain. Cell47, 333―348.
doi: 10.1016/0092-8674(86)90590-8
|
|
O'Brien, W.A., Koyanagi, Y., Namazie, A., Zhao, J.Q., Diagne, A., Idler, K., Zack, J.A., and Chen, I.S.(1990). HIV-1 tropism formononuclear phagocytes can be determined by regions of gp120 outsidethe CD4-binding domain. Nature348, 69―73.
|
|
Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J.M., Clark-Lewis, I., Legler, D.F., et al.(1996). The CXC chemokine SDF-1 is the ligandfor LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature382, 833―835.
doi: 10.1038/382833a0
|
|
Pillai, S., Good, B., Richman, D., and Corbeil, J.(2003). A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses19, 145―149.
doi: 10.1089/088922203762688658
|
|
Resch, W., Hoffman, N., and Swanstrom, R.(2001). Improvedsuccess of phenotype prediction of the human immunodeficiency virustype 1 from envelope variable loop 3 sequence using neural networks. Virology288, 51―62.
doi: 10.1006/viro.2001.1087
|
|
Schuitemaker, H., Groenink, M., Tersmette, M., and Miedema, F.(1993). HIV tropism. Nature 361, 310.
doi: 10.1038/361310a0
|
|
Shioda, T., Levy, J.A., and Cheng-Mayer, C.(1991). Macrophageand T cell-line tropisms of HIV-1 are determined by specific regionsof the envelope gp120 gene. Nature349, 167―169.
doi: 10.1038/349167a0
|
|
Sing, T., Low, A.J., Beerenwinkel, N., Sander, O., Cheung, P.K., Domingues, F.S., Büch, J., D?umer, M., Kaiser, R., Lengauer, T., et al. (2007). Predicting HIV coreceptor usage on the basisof genetic and clinical covariates. AntivirTher12, 1097―1106.
|
|
Tersmette, M., Gruters, R.A., de Wolf, F., de Goede, R.E., Lange, J.M., Schellekens, P.T., Goudsmit, J., Huisman, H.G., and Miedema, F.(1989). Evidence for a roleof virulent human immunodeficiency virus (HIV) variants in the pathogenesisof acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol63, 2118―2125.
|
|
Trouplin, V., Salvatori, F., Cappello, F., Obry, V., Brelot, A., Heveker, N., Alizon, M., Scarlatti, G., Clavel, F., and Mammano, F.(2001). Determinationof coreceptor usage of human immunodeficiency virus type 1 from patientplasma samples by using a recombinant phenotypic assay. J Virol75, 251―259.
doi: 10.1128/JVI.75.1.251-259.2001
|
|
Van Baelen, K., Vandenbroucke, I., Rondelez, E., Van Eygen, V., Vermeiren, H., and Stuyver, L.J. (2007). HIV-1coreceptor usage determination in clinical isolates using clonal andpopulation-based genotypic and phenotypic assays. J Virol Methods146, 61―73.
doi: 10.1016/j.jviromet.2007.06.003
|
|
Weiner, D.B., Huebner, K., Williams, W.V., and Greene, M.I.(1991). Human genes other than CD4 facilitate HIV-1 infectionof murine cells. Pathobiology59, 361―371.
doi: 10.1159/000163679
|
|
Whitcomb, J.M., Huang, W., Fransen, S., Limoli, K., Toma, J., Wrin, T., Chappey, C., Kiss, L.D., Paxinos, E.E., and Petropoulos, C.J.(2007). Development and characterization of a novel single-cyclerecombinant-virus assay to determine human immunodeficiency virustype 1 coreceptor tropism. Antimicrob AgentsChemother51, 566―575.
doi: 10.1128/AAC.00853-06
|
|
Wu, L., Gerard, N.P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A.A., Desjardin, E., Newman, W., et al. (1996). CD4-induced interaction of primary HIV-1 gp120 glycoproteins withthe chemokine receptor CCR-5. Nature384, 179―183.
doi: 10.1038/384179a0
|
|
Wyatt, R., and Sodroski, J.(1998). The HIV-1envelope glycoproteins: fusogens, antigens, and immunogens. Science280, 1884―1888.
doi: 10.1126/science.280.5371.1884
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
